Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
Why Is American Well Corporation (AMWL) Stock Down -12.08% Today?

Why Is American Well Corporation (AMWL) Stock Down -12.08% Today?

Key Takeaways

  • AMWL shares were down roughly 12% in Friday's session, reversing the prior day's sharp advance.
  • The pullback reflects broad profit-taking after a steep multi-week rally that pushed the stock well above consensus analyst price targets.
  • Investors appear to be de-risking ahead of the company's third-quarter earnings report, scheduled for after the close on November 3.
  • The move diverges from a relatively stable broader market and is concentrated in the small-cap telehealth name rather than the wider healthcare sector.
  • Traders are watching next week's earnings, subscription revenue trends, and the path toward cash-flow breakeven as key catalysts.
  • For deeper analysis, explore Price Targets, Earnings, and Forecast data on additional pages.
  • Discover actionable trading ideas with Tickeron's Trending AI Robots.

Opening Summary

American Well Corporation (AMWL), doing business as Amwell, is a Boston-based digital care enablement company that connects providers, payers, and patients through its hybrid-care and virtual-health platform. In Friday's session, the stock fell about 12.08% to roughly $13.17, down from Thursday's closing price of $14.98. The decline represents a sharp reversal of the 6% gain booked in the prior session and underscores how quickly momentum can unwind in a small-cap name that has run far ahead of fundamental expectations.

Profit-Taking After a Parabolic Rally

The most direct driver of Friday's decline appears to be profit-taking following an extended run-up. AMWL shares have climbed dramatically from their 52-week low of $3.71, more than tripling in value as investors rewarded the company's improving cost discipline and growing backlog of government and enterprise contracts. When a stock appreciates that quickly, even the absence of negative news can trigger sharp reversals, as traders lock in gains and momentum strategies unwind. Friday's double-digit slide fits the pattern of a mean-reversion move in an overheated rally rather than a fundamental breakdown.

Valuation Running Ahead of Analyst Targets

A key point of tension in the market is that AMWL had traded well above the consensus view of Wall Street. Most analysts maintain a "Hold" rating, and average 12-month price targets have remained meaningfully below the stock's recent highs. The gap between the share price and sell-side targets made the stock vulnerable to a correction, and Friday's move can be seen as the market bringing the price back toward a level more consistent with near-term estimates. The company's revenue base is still contracting as it transitions toward its Converge software platform, a dynamic that complicates a valuation case built primarily on momentum.

De-Risking Ahead of Third-Quarter Earnings

Timing also matters. Amwell is scheduled to report third-quarter results after the market closes on Tuesday, November 3, and investors frequently trim positions into a print they perceive as uncertain. Analysts expect quarterly revenue of roughly $47 million, down approximately 16% year over year, even as the company continues to narrow its losses. While Amwell raised its full-year profitability outlook earlier in the year and has signaled progress toward operating and cash-flow breakeven, shrinking subscription and top-line revenue remain headwinds. With the stock having already surged on earnings anticipation, the risk-reward setup heading into the report appears less favorable, prompting some holders to sell before the news.

Market Context and Trading Activity

The decline in AMWL was largely idiosyncratic rather than a reflection of broad market weakness. Major equity indices were not moving in sympathy with the double-digit drop, suggesting the selling was concentrated in the stock itself. Trading activity has been elevated in recent sessions, with volume running well above the company's typical daily average as the rally attracted speculative interest. After Thursday's higher-than-average turnover, Friday's pullback likely reflected aggressive unwinding of that same short-term positioning. The stock's high beta and historically thin float amplify both up and down moves, making sharp swings like this more common.

What Comes Next for AMWL

The immediate focus is next week's third-quarter earnings report and management's commentary on the fourth-quarter path to cash-flow breakeven. Investors will scrutinize subscription revenue trends, gross margins, and any update on the company's government opportunities, including the letter of intent from the Department of Veterans Affairs and its defense health contracts. Analyst expectations remain cautious, and the direction of the stock may hinge on whether the company can demonstrate durable revenue stabilization alongside continued cost control. Key risks include further insider selling, ongoing top-line contraction during the platform transition, and the possibility that valuation remains stretched relative to fundamentals. As always, single-session moves in a low-float, high-volatility stock should be viewed in the context of the broader multi-week trend.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that have demonstrated strength under current market conditions. Tickeron offers hundreds of automated trading bots covering thousands of tickers, each differing in strategy, timeframe, performance metrics, and traded symbols. Only the strongest performers are featured in the Trending AI Robots section, giving traders a focused way to explore quantitative approaches to the market. To see which strategies are currently leading, visit the Trending AI Robots page and discover tools that may complement your own research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMWL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AMWL sees MACD Histogram just turned negative

AMWL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In 36 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMWL as a result. In 79 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

AMWL moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMWL crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMWL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for AMWL entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMWL's RSI Indicator exited the oversold zone, 24 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +10.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMWL advanced for three days, in 181 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

AMWL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.916) is normal, around the industry mean (4.523). P/E Ratio (-2.492) is within average values for comparable stocks, (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.006) is also within normal values, averaging (6.105).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. AMWL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMWL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.31B. The market cap for tickers in the group ranges from 708 to 49.18B. VEEV holds the highest valuation in this group at 49.18B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -13%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was 2%. DRIO experienced the highest price growth at 5%, while LFMD experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 58
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: -5 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Industry
N/A
Address
75 State Street
Phone
+1 617 204-3500
Employees
562
Web
https://business.amwell.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.